Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 278

1.

What can we learn from oncology surgical trials?

Evrard S, McKelvie-Sebileau P, van de Velde C, Nordlinger B, Poston G.

Nat Rev Clin Oncol. 2016 Jan;13(1):55-62. doi: 10.1038/nrclinonc.2015.176. Epub 2015 Oct 20. Review.

PMID:
26483296
2.

Prognostic impact of immune response in resectable colorectal liver metastases treated by surgery alone or surgery with perioperative FOLFOX in the randomised EORTC study 40983.

Tanis E, Julié C, Emile JF, Mauer M, Nordlinger B, Aust D, Roth A, Lutz MP, Gruenberger T, Wrba F, Sorbye H, Bechstein W, Schlag P, Fisseler A, Ruers T.

Eur J Cancer. 2015 Nov;51(17):2708-17. doi: 10.1016/j.ejca.2015.08.014. Epub 2015 Sep 2.

PMID:
26342674
3.

Reply to J.N. Primrose et al and C.-H. Köhne.

Nordlinger BM, Poston GJ, Goldberg RM.

J Clin Oncol. 2015 Jul 20;33(21):2408-9. doi: 10.1200/JCO.2014.60.4751. Epub 2015 Jun 1. No abstract available.

4.

Prognostic score for recurrence after Whipple's pancreaticoduodenectomy for ampullary carcinomas; results of an AGEO retrospective multicenter cohort.

Colussi O, Voron T, Pozet A, Hammel P, Sauvanet A, Bachet JB, Vaillant JC, Rougier P, Nordlinger B, Berger A, Coriat R, Dousset B, Malka D, André T, Paye F, Aparicio T, Locher C, Cojean Zeleck D, Tchinou L, Bonnetain F, Taieb J.

Eur J Surg Oncol. 2015 Apr;41(4):520-6. doi: 10.1016/j.ejso.2015.01.010. Epub 2015 Jan 24.

PMID:
25680954
5.

Pathological response of locally advanced rectal cancer to preoperative chemotherapy without pelvic irradiation.

Bensignor T, Brouquet A, Dariane C, Thirot-Bidault A, Lazure T, Julié C, Nordlinger B, Penna C, Benoist S.

Colorectal Dis. 2015 Jun;17(6):491-8. doi: 10.1111/codi.12879.

PMID:
25524450
6.

Should the results of the new EPOC trial change practice in the management of patients with resectable metastatic colorectal cancer confined to the liver?

Nordlinger B, Poston GJ, Goldberg RM.

J Clin Oncol. 2015 Jan 20;33(3):241-3. doi: 10.1200/JCO.2014.58.3989. Epub 2014 Nov 17. No abstract available.

7.

Can we predict complete or major response after chemoradiotherapy for rectal cancer by noninvasive methods? Results of a prospective study on 61 patients.

Moszkowicz D, Peschaud F, El Hajjam M, Julié C, Beauchet A, Penna C, Nordlinger B, Benoist S.

Am Surg. 2014 Nov;80(11):1136-45.

PMID:
25347506
8.

Metastatic colorectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Van Cutsem E, Cervantes A, Nordlinger B, Arnold D; ESMO Guidelines Working Group.

Ann Oncol. 2014 Sep;25 Suppl 3:iii1-9. doi: 10.1093/annonc/mdu260. Epub 2014 Sep 4. No abstract available. Erratum in: Ann Oncol. 2015 Sep;26 Suppl 5:v174-7.

9.

Management of patients over 80 years of age treated with resection for localised colon cancer: results from a French referral centre.

Lièvre A, Laurent V, Cudennec T, Peschaud F, Malafosse R, Benoist S, Penna C, Lepère C, Vaillant JN, Julié C, Teillet L, Nordlinger B, Rougier P, Mitry E.

Dig Liver Dis. 2014 Sep;46(9):838-45. doi: 10.1016/j.dld.2014.05.005. Epub 2014 Jun 5.

PMID:
24908573
10.

Minimally-invasive approach for rectal cancer surgery.

Brouquet A, Nordlinger B.

Lancet Oncol. 2014 Jun;15(7):680-1. doi: 10.1016/S1470-2045(14)70233-5. Epub 2014 May 15. No abstract available.

PMID:
24837214
11.

Reply to letter: "Predictive factors for the benefit of perioperative FOLFOX for resectable liver metastasis in colorectal cancer patients (EORTC Intergroup Trial 40983)".

Sorbye H, Mauer M, Nordlinger B.

Ann Surg. 2015 Jan;261(1):e29. doi: 10.1097/SLA.0000000000000659. No abstract available.

PMID:
24646558
12.

Local recurrence rates after radiofrequency ablation or resection of colorectal liver metastases. Analysis of the European Organisation for Research and Treatment of Cancer #40004 and #40983.

Tanis E, Nordlinger B, Mauer M, Sorbye H, van Coevorden F, Gruenberger T, Schlag PM, Punt CJ, Ledermann J, Ruers TJ.

Eur J Cancer. 2014 Mar;50(5):912-9. doi: 10.1016/j.ejca.2013.12.008. Epub 2014 Jan 7.

PMID:
24411080
13.

Early colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Labianca R, Nordlinger B, Beretta GD, Mosconi S, Mandalà M, Cervantes A, Arnold D; ESMO Guidelines Working Group.

Ann Oncol. 2013 Oct;24 Suppl 6:vi64-72. doi: 10.1093/annonc/mdt354. No abstract available.

14.

Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial.

Nordlinger B, Sorbye H, Glimelius B, Poston GJ, Schlag PM, Rougier P, Bechstein WO, Primrose JN, Walpole ET, Finch-Jones M, Jaeck D, Mirza D, Parks RW, Mauer M, Tanis E, Van Cutsem E, Scheithauer W, Gruenberger T; EORTC Gastro-Intestinal Tract Cancer Group; Cancer Research UK; Arbeitsgruppe Lebermetastasen und–tumoren in der Chirurgischen Arbeitsgemeinschaft Onkologie (ALM-CAO); Australasian Gastro-Intestinal Trials Group (AGITG); Fédération Francophone de Cancérologie Digestive (FFCD).

Lancet Oncol. 2013 Nov;14(12):1208-15. doi: 10.1016/S1470-2045(13)70447-9. Epub 2013 Oct 11.

PMID:
24120480
15.

Multicenter validation study of pathologic response and tumor thickness at the tumor-normal liver interface as independent predictors of disease-free survival after preoperative chemotherapy and surgery for colorectal liver metastases.

Brouquet A, Zimmitti G, Kopetz S, Stift J, Julié C, Lemaistre AI, Agarwal A, Patel V, Benoist S, Nordlinger B, Gandini A, Rivoire M, Stremitzer S, Gruenberger T, Vauthey JN, Maru DM.

Cancer. 2013 Aug 1;119(15):2778-88. doi: 10.1002/cncr.28097. Epub 2013 Apr 23.

16.

[Tolerance and efficacy of preoperative radiation therapy for elderly patients treated for rectal cancer].

Le Fur E, Chatellier G, Berger A, Emile JF, Dousset B, Nordlinger B, Berges O, Deberne M, Dessard-Diana B, Henni M, Giraud P, Housset M, Durdux C.

Cancer Radiother. 2013 Jun;17(3):202-7. doi: 10.1016/j.canrad.2013.01.013. Epub 2013 May 2. French.

PMID:
23643361
17.

Response of liver metastases to preoperative radiochemotherapy in patients with locally advanced rectal cancer and resectable synchronous liver metastases.

Manceau G, Brouquet A, Bachet JB, Penna C, El Hajjam M, Rougier P, Nordlinger B, Benoist S.

Surgery. 2013 Sep;154(3):528-35. doi: 10.1016/j.surg.2013.02.010. Epub 2013 Apr 16.

PMID:
23601902
18.

Metastatic colorectal cancer outcome and fatty liver disease.

Brouquet A, Nordlinger B.

Nat Rev Gastroenterol Hepatol. 2013 May;10(5):266-7. doi: 10.1038/nrgastro.2013.53. Epub 2013 Apr 9. Review.

PMID:
23567218
19.

Systemic cytotoxic and biological therapies of colorectal liver metastases: expert consensus statement.

Schwarz RE, Berlin JD, Lenz HJ, Nordlinger B, Rubbia-Brandt L, Choti MA.

HPB (Oxford). 2013 Feb;15(2):106-15. doi: 10.1111/j.1477-2574.2012.00558.x. Epub 2012 Sep 24.

20.

Surgical strategies to synchronous colorectal liver metastases.

Brouquet A, Nordlinger B.

Dig Dis. 2012;30 Suppl 2:132-6. doi: 10.1159/000342043. Epub 2012 Nov 23. Review.

PMID:
23207945
Items per page

Supplemental Content

Loading ...
Write to the Help Desk